EFFICIENCY AND SAFETY OF ISIDA COSMETIC AGENTS IN THE TREATMENT OF CHILDREN WITH ATOPIC DERMATITIS

I. A Gorlanov; L. M Leina; I. R Milyavskaya; S. Yu Kulikova

doi:10.17816/dv36742

Russian Journal of Skin and Venereal Diseases ›› 2012, Vol. 15 ›› Issue (6) : 27 -30. DOI: 10.17816/dv36742

Articles

research-article

EFFICIENCY AND SAFETY OF ISIDA COSMETIC AGENTS IN THE TREATMENT OF CHILDREN WITH ATOPIC DERMATITIS

Author information +

History +

PDF

Abstract

Atopic dermatitis is one of the prevalent skin diseases. Drugs for external therapy of chronic dermatosis in children should allow free transport of active substances to the cell-cell space and inside the cells, should spare the lipid barrier structure, restore the epidermal barrier and be incorporate in it, filling the damaged sites. Isida, a series of modern liposomal cosmetic means with a DAS (Dorogov ’s antiseptic stimulant), is characterized by these activities. The efficiency of Isida external agents in children with atopic dermatitis is demonstrated. The treatment efficiency was evaluated by the time course of SCORAD (Scoring of Atopic Dermatitis) index and the children ’s quality of life dermatological index.

Keywords

atopic dermatitis / epidermal barrier / quality of life / Isida liposomal cosmetic preparations

Cite this article

Download citation ▾

I. A Gorlanov, L. M Leina, I. R Milyavskaya, S. Yu Kulikova. EFFICIENCY AND SAFETY OF ISIDA COSMETIC AGENTS IN THE TREATMENT OF CHILDREN WITH ATOPIC DERMATITIS. Russian Journal of Skin and Venereal Diseases, 2012, 15(6): 27-30 DOI:10.17816/dv36742

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Атопический дерматит у детей: диагностика, лечение и профилактика: Научно-практическая программа. М.: Информатик; 2001.

[2]	Короткий Н.Г., ред. Атопический дерматит у детей: Руководство для врачей. Тверь: Триада; 2003.

[3]	Hanifin J.M., Chan S.C. Diagnosis and treatment of atopic dermatitis. Dermatol. Therapy. 1996; 1: 9—18.

[4]	Paller Amy S., Mancini A.J. Hurwitz clinical pediatric dermatology: A textbook of skin disorders of childhood and adolescence. Elsevier Saunders; 2011.

[5]	Weston W.L., Lane A.T., Morelli J.G. Color textbook of pediatric dermatology. Philadelphia: Mosby; 2007.

[6]	Белоусова Т.А., Горячкина М.В., Филиппова В.А. Consilium medicum. Дерматология. 2009; 3: 15—8.

[7]	Скрипкин Ю.К., Мордовцев В.Н., ред. Клиническая дерматовенерология: Руководство для врачей. М.: ГЭОТАР-Медиа; 2009: т. 2.

[8]	Кубанова А.А., ред. Клинические рекомендации. Дерматовенерология. М.: ДЭКС-Пресс; 2007.

[9]	Ott H., Hoeger P. Treatment of atopical eczema in childhood. Padiatrische Praxis 2004; 65: 445—58.

[10]	Aubert-Wastiaux H., Moret L., Le Rhun A., Fontenoy A.M., Nguyen J.M., Leux C., et al. Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency. Br. J. Dermatol. 2011; 165(4): 808—14. doi: 10.1111/j.1365-2133.2011.10449.x

[11]	Ключарева С.В. Результаты сравнительного исследования косметической линии «Айсида» и стандартных схем терапии у пациентов с чувствительной кожей и хроническими дерматозами. М.; 2010.

[12]	Hanifin J.M., Rajka G. Diagnostic features of atopic dermatitis. Acta Derm. Venerol. 1980; 114(suppl) (Stockh.): 146—8.

[13]	Uter W., Schwanitz H.J., Pfahlberg A., Gefeller O. Atopic signs and symptoms: assessing the 'atopy score' concept. Dermatology. 2001; 202(1): 4—8.

[14]	Williams H.C., Burney P.G., Pembroke A.C., Hay R.J. Validation of the U.K. diagnostic criteria for atopic dermatitis in a population setting. U.K. Diagnostic Criteria for Atopic Dermatitis Working Party. Br. J. Dermatol. 1996; 135(1): 12—7.

[15]	Каурова Т.В. Изучение качества жизни в детской дерматологической практике. В кн.: Материалы II Российской научно-практической конференции «Аллергические и иммунопатологические заболевания — проблема XXI века». СПб.; 2010: 21—2.